 |
June 2, 2008 - Cougar Biotechnology Presents Positive CB7630 (Abiraterone Acetate) Phase I and Phase II Data at ASCO 2008 Annual Meeting
Read » | PDF »
|
|
Cougar Biotechnology is a publicly traded biotechnology company established to in-license and develop early clinical stage drugs, with a specific focus on the field of oncology. To communicate with Cougar about a specific licensing opportunity, please contact Licensing.
|
| | |
Cougar Biotechnology, Inc.
10990 Wilshire Blvd, Suite 1200
Los Angeles, CA 90024
(310) 943-8040 Main
(310) 943-8059 Fax
|
